Encore Properties: The Maturity Schedule, the Collateral, and What Really Gets Tested in 2026
Even after ending 2025 with $47 million of cash and restricted cash, Encore's 2026 test is highly concentrated: $54.8 million of current bonds and $25.0 million of current loans, led by Series D and Northpoint Center. The issue now is not whether the assets exist, but whether the collateral package and Northpoint's lease-up are strong enough to get through the refinancing window without a weaker negotiating position.
Where The Main Article Stopped
The main article argued that the improvement in NOI, operating cash flow, and headline cash did not close the 2026 question on its own. This follow-up isolates that issue directly: Encore's 2026 wall is less a story of missing assets and more a story of maturity structure, collateral quality, and refinancing timing.
What matters is that the balance sheet looks milder than the contractual maturity table. The statement of financial position shows $54.8 million of current bonds and $25.0 million of current loans. But in the liquidity-risk table, meaning the cash that actually has to go out by the end of 2026 including interest, the same up-to-one-year bucket rises to $70.8 million for bonds and $34.2 million for bank and financial debt. That is not the same number, and it is not the same pressure level.
Against that wall, Encore ended 2025 with about $44.8 million of cash and cash equivalents and another $2.2 million of restricted cash. The company states that there is no warning sign and that its cash flow forecasts point to sufficient sources under reasonable assumptions. So this is not a solvency piece. It is about a different question: how much negotiating room the company really has when the July and August 2026 front end is already in view.
Four points to keep in mind before going deeper:
- The accounting wall is smaller than the cash wall. The balance sheet shows $79.8 million of current debt, but contractual bond and loan payments due within a year rise to $104.9 million.
- The wall is highly concentrated. Most of it sits in Series D at $44.8 million and Northpoint Center at $23.7 million.
- The collateral is not one uniform package. Series D is backed by pledged assets with about 67% LTV at year-end, while Northpoint is an asset acquired only in April 2025, with 77% occupancy at year-end and a loan maturing in August 2026.
- Covenants are not the immediate problem. The company says it is in compliance with Series C, D, and E covenants, and year-end equity of $170.3 million sits well above the $55 million, $65 million, and $70 million equity floors. The test is refinancing, not a technical breach.
The Maturity Schedule: What The Balance Sheet Does Not Show
The $40.9 million consolidated working-capital deficit looks severe at first glance. But the report itself gives a precise explanation: it mostly comes from two familiar lines, current bonds, mainly Series D, and current loans, mainly Northpoint. That is where the key distinction starts. The statement of financial position shows the current principal classification. The liquidity-risk table shows the cash that actually needs to leave, including interest. For debt investors, that is the more relevant table.
That gap matters because it explains why the cash balance alone does not settle the debate. Even using the broader presentation framing, meaning $47.0 million of cash including restricted cash, that balance is still below contractual bond payments due within a year and far below total contractual bond and loan payments. Looking only at the cash balance misses the structure.
The 2025 cash flow statement also does not support the view that the wall has already been self-funded. Operating cash flow improved to $26.6 million, but it sat against $147.2 million of investing outflow and $157.8 million of financing inflow. That financing line also included about $32 million of owner capital injected in cash. The implication is straightforward: 2025 improved the starting point, but it did not remove reliance on refinancing and an open debt market.
This is why 2026 is a concentrated test rather than a vague capital-structure discussion. Out of $54.8 million of current bonds, about $44.8 million sits in Series D. Out of $25.0 million of current loans, about $23.7 million sits in Northpoint. In other words, the practical front end of 2026 comes down to two large financing decisions, not dozens of small items.
What Actually Sits Behind Each Liability
| Exposure | Relevant amount | Timing | What the collateral tells you | What is really being tested |
|---|---|---|---|---|
| Series D | $44.8 million of current principal | July 2026 | The annual report points to about 67% LTV against pledged assets, and the presentation marks Darlington Square and Washington Plaza as pledged to Series D | Whether the bullet can be refinanced or repaid without tightening the collateral package further |
| Series C | $10.0 million of current principal | Through 2026, final maturity in July 2027 | Amortizing series with a lower $55 million equity floor | More background pressure than the defining wall |
| Northpoint Center | $23.7 million | August 2026 | The report says financed assets carry first-ranking liens on property rights and rent proceeds; the presentation shows Northpoint at a $37.1 million asset value and 64% LTV | Whether the asset can reach refinancing in stronger operating shape rather than as a transition asset |
| Series E | No current principal in 2026 | First principal in July 2027 | Raised in 2025 and expanded again in October; a $32 million capital or subordinated-owner-loan commitment accompanied the deal | A back-end duration extension, not a fix for the front end of 2026 |
Series D: The Big Liability And The Collateral That Has To Work
Series D is the core of the test. It is a bullet maturity, with principal due on July 15, 2026. The report makes clear that most of current bond debt comes from this series and adds that year-end LTV against the pledged assets stood at about 67%, excluding cash. In the presentation, two retail assets, Darlington Square and Washington Plaza, are marked as pledged to Series D.
What does that mean in practice? First, the series is not currently being tested through a covenant breach. Its equity floor is $65 million, while the company ended the year with $170.3 million of equity. The maximum adjusted net debt to net CAP ratio, 80%, is not presented as a current problem either, and the company explicitly says it is in compliance. So Series D is a debt-market and collateral event, not an immediate trust-deed violation event.
That distinction matters. Markets sometimes confuse "in covenant compliance" with "easy to refinance." Those are not the same thing. Encore reaches July 2026 without an immediate accounting distress signal, but also without a cash position that makes the refinancing event irrelevant.
Northpoint: Here Collateral Quality Depends On An Operating Timeline
If Series D is a debt-market test, Northpoint is an asset test. The remaining principal is about $23.7 million, with maturity in August 2026. According to the presentation, the asset was worth $37.1 million at year-end, LTV was 64%, and occupancy was 77%. That is reasonable for an asset acquired only in April 2025, but it is not the kind of metric that creates full comfort when refinancing is less than a year away.
The encouraging piece is that the company signed a lease with retail chain Uncharted for about 15 thousand SF, with the lease expected to begin in February 2026 and take occupancy to about 82%. The first trigger here is not a financing deal. It is a leasing event. If that lease starts on time and lifts occupancy, Northpoint should reach refinancing with a better negotiating position. If not, the company may end up refinancing an asset that still has not reached the level of stability it wants to show.
The collateral structure matters as well. The report says the consolidated and equity-accounted entities carry first-ranking liens on their rights in the properties and on rental receipts in favor of bank and other lenders. So even in Northpoint's case, this is not just a discussion about book value or LTV. It is an asset entering the refinancing window inside a hard-collateral framework, which means occupancy and NOI quality through August 2026 matter directly.
Series C And E: What Helps, And What Does Not
Series C is less dramatic because it amortizes rather than maturing in one bullet. At the end of 2025 it had $10.0 million in current maturities and another $20.2 million in long-term liabilities, with final maturity in July 2027. It adds cash pressure, but it is not the wall that defines the year.
Series E matters because of what it is not. The company raised it in August 2025 and expanded it again in October, for net proceeds of about $71.4 million and another $39.8 million. The first principal payment only starts in July 2027, so this series did extend duration on the back end of the structure. In addition, the issuance and expansion came with a commitment by controlling shareholders to inject about $32 million, completed in August and November 2025. That means 2025 already included an active move to strengthen the capital structure and push part of the maturity load outward. Precisely because of that, the fact that Series D and Northpoint still remain at the front end of 2026 stands out even more.
Covenants Are Not The Immediate Fire, FX Can Still Move The Picture
From a covenant standpoint, the picture is relatively calm. The equity floors are $55 million for Series C, $65 million for Series D, and $70 million for Series E. The company says it meets all covenant tests, and year-end equity was $170.3 million. That looks like comfortable room.
But there is another variable that is hard to ignore, FX. Net bonds outstanding, including accrued interest, amounted to about $198.8 million at the end of 2025, while shekel-denominated cash and restricted cash amounted to only about $0.9 million. That leaves material shekel versus dollar exposure in place. A 5% move in the dollar against the shekel translates into about $9.9 million of impact on total comprehensive income, and 2025 already carried $15.1 million of FX expense.
FX does not create July and August 2026, but it can clearly move the accounting and financing picture on the way there. If the dollar weakens against the shekel, the shekel bond burden rises in dollar terms. If the dollar strengthens, the opposite happens. So even though 2026 is mainly a refinancing question, it is not detached from the currency market.
What Has To Happen Before 2026
The report itself tries to calm the picture. The company says the sources it identifies are realistic, that monthly cash flow forecasts point to sufficient liquidity, and that there is no warning sign. That matters, but it does not replace the three execution tests the market is likely to focus on:
- Series D needs to be repaid or rolled without creating the sense that the company is paying again through heavier collateral or greater owner dependence.
- Northpoint needs to show that the Uncharted lease really begins in February 2026 and that occupancy moves toward 82% before August.
- Liquidity needs to remain reasonable without replaying a 2025-style move, meaning no fresh owner capital injection on the scale of $32 million and no new debt raise simply to stabilize the starting point.
That leads to the broader conclusion. Encore is not being judged in 2026 on whether assets exist or whether there is theoretical value on paper. It is being judged on whether asset value, NOI, and the stronger equity base can be translated into a calmer debt structure at the near end of the curve.
Bottom Line
This is not a property-value test. It is a synchronization test. Series D needs a solution by July 2026, Northpoint needs to arrive in better shape by August 2026, and all of this is happening while the year-end cash balance was built with debt issuance and owner capital as well as operating cash flow.
So the practical question is not whether Encore can point to better assets. It is whether the company can get through 2026 without turning the 2025 improvement into a weaker negotiating position with lenders. If the answer is yes, 2025 will look like a genuine duration-extension year. If not, it will look more like a year that mainly bought time.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.